test

Ilko Menkov

@Vestal Point Capital, Lp

Latest period2024 - Q3ReportedManaged Assets$1.319BTotal holdings69
Assets growth rate-1.67%Assets growth rate (2-Q avg)4.62%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Vestal Point Capital, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 69 positions.

Assets under management

The assets under management (AUM) of Vestal Point Capital, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.319B in assets, with a quarterly growth rate of -1.67% and a 2-quarter average growth rate of 4.62%. The portfolio is managed by Ilko Menkov, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
INSMInsmed Inc
Recent Activity
Increased 113.34%
8.86%
$116.8M
1.6M shares@ $73.0 avg price
JAZZJazz Pharmaceuticals Plc
Recent Activity
Decreased -40%
7.61%
$100.269M
900,000 shares@ $111.41 avg price
CYTKCytokinetics Inc
Recent Activity
Decreased -27.71%
6.01%
$79.2M
1.5M shares@ $52.8 avg price
NARIInari Medical Inc
Recent Activity
Increased 342.86%
4.85%
$63.922M
1.55M shares@ $41.24 avg price
ACLXArcellx Inc
Recent Activity
4.28%
$56.369M
675,000 shares@ $83.51 avg price
GPCRStructure Therapeutics Inc
Recent Activity
Increased 105.36%
3.83%
$50.474M
1.15M shares@ $43.89 avg price
KALVKalvista Pharmaceuticals Inc
Recent Activity
Increased 73.92%
3.52%
$46.32M
4M shares@ $11.58 avg price
ATXSAstria Therapeutics Inc
Recent Activity
Increased 23.08%
3.34%
$44.04M
4M shares@ $11.01 avg price
IMTXImmatics Nv
Recent Activity
Increased 36.37%
3.25%
$42.788M
3.75M shares@ $11.41 avg price
RAREUltragenyx Pharmaceutical Inc
Recent Activity
Decreased -58.33%
3.16%
$41.663M
750,000 shares@ $55.55 avg price